We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
CSLR | Complete Solaria Inc | 0.7303 | 0.3494 | 91.73% | 25,793,969 |
MULN | Mullen Automotive Inc | 5.73 | 2.57 | 81.33% | 72,115,814 |
DCPH | Deciphera Pharmaceuticals Inc | 25.28 | 10.63 | 72.56% | 50,723,870 |
CAUD | Collective Audience Inc | 0.6377 | 0.2477 | 63.51% | 157,725,466 |
LICN | Lichen China Limited | 2.03 | 0.66 | 48.18% | 3,964,175 |
HWH | HWH International Inc | 2.5899 | 0.7699 | 42.30% | 35,335,015 |
VAXX | Vaxxinity Inc | 0.1579 | 0.0413 | 35.42% | 6,225,541 |
SINT | SiNtx Technologies Inc | 0.053477 | 0.01308 | 32.37% | 174,364,047 |
PAHC | Phibro Animal Health Corporation | 16.82 | 4.09 | 32.13% | 787,001 |
OLB | OLB Group Inc | 0.4768 | 0.1156 | 32.00% | 601,198 |
TSLL | Direxion Daily TSLA Bull 2X Trust ETF | 9.3599 | 2.21 | 30.91% | 83,233,075 |
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd. (ONO), under which ONO will acquire all outstanding shares of Deciphera common stock for $25.60 per share in cash through a tender offer followed by a merger of Deciphera with a wholly-owned subsidiary of ONO (the “Acquisition”), for a total equity value of $2.4 billion. The boards of directors of both companies have unanimously approved the transaction.
Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.
HANGZHOU, China, April 29, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 0.9 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for aggregate gross proceeds of approximately $1.53 million. The closing of the sale of the securities is expected to occur on or about April 30, 2024, subject to ...
NEW YORK, April 29, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Heartland Financial, USA Inc. (NASDAQ: HTLF) and its board of directors concerning the proposed acquisition of the company by UMB Financial Corporation (NASDAQ: UMBF). Stockholders will receive 0.55 shares of UMB Financial common stock for each share of Heartland Financial stock that they hold. The transaction is valued at approximately $2 billion and is expected to close first quarter of 2025.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 63,955.86 | 120.50 | 0.19% | 1.25T | 3,818,812,494 |
ETH | Ethereum | 3,216.96 | 2.08 | 0.06% | 385.18B | 2,697,572,124 |
USDT | Tether USD | 0.9998 | 0.00015 | 0.02% | 97.82B | 238,709,763 |
BNB | Binance Coin | 596.52 | 3.98 | 0.67% | 93.84B | 250,956,946 |
SOL | Solana | 138.06 | 0.350 | 0.25% | 60.43B | 960,202,791 |
STETH | stETH | 3,212.18 | -0.769538 | -0.02% | 31.41B | 6,045,587 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 956,563,459 |
XRP | Ripple | 0.5148 | -0.0002 | -0.04% | 28.05B | 317,428,090 |
DOGE | Dogecoin | 0.14411 | 0.00075 | 0.52% | 20.49B | 344,045,243 |
TONCOIN | Wrapped TON Coin | 5.31 | -0.007058 | -0.13% | 18.35B | 49,097,545 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions